Albert Weber to join OpGen as OpGen’s CFO effective January 1, 2022 from U.S.-German molecular diagnostics company Epigenomics Announces inducement grant of 210,000 stock options under NASDAQ Listing Rule 5635(c)(4)
Albert Weber to join OpGen as OpGen’s CFO effective January 1, 2022 from U.S.-German molecular diagnostics company EpigenomicsAnnounces inducement grant of.
OpGen’s Acuitas® AMR Gene Panel allows testing for a comprehensive panel of 28 genetic AMR markers in isolated bacterial colonies from 26 different pathogensAn aid to clinicians in the management